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Summary The objective of this study was to test the hypothesis that a positive relationship exists between
high levels of serum cholesterol and primary brain tumours. A record-based case-control study was performed
on male Jewish residents of Israel who were hospitalized at the Hadassah Ein Karem hospital in the years
1978-1982. A record check identified 37 cases of brain tumour who fulfilled the criteria for inclusion in the
study and whose hospital files included the necessary data. For each case two controls were chosen randomly
from all patients with inguinal hernia who met the respective matching criteria of age and year of
hospitalization. The mean cholesterol value of the cases with brain tumours was 22 mgdl-1 higher than that
of the controls. This difference was statistically significant (P=0.007). Controlling for weight, region of birth,
season of year, social class, medications and length of hospitalization before the measurement of cholesterol
did not reduce the cholesterol difference, and in some instances increased it.
In recent years, there has been considerable interest
in the study of the relationship of serum cholesterol
with cancer incidence and mortality (Hlatky &
Hulley, 1981; Levy, 1982; Feinleib, 1983;
McMichael et al., 1984). A number of studies have
shown an inverse association in men, though
usually not in women, whereas in other reports
there was no relationship. The most consistent
(inverse) association was for cancer of the colon.
Two population-based prospective studies in Israel,
the Kiryat Hayovel Community Health Study in
Jerusalem and the Israel Ischemic Heart Disease
Study showed higher levels of serum cholesterol
(with mean differences of about 20mgdl-1 and
16mgdl1 respectively) in the small numbers (5
and 17 respectively) of subjects who died of
intracranial tumours during follow-up (Kark et al.
and Goldbourt et al., unpublished observations). A
small case-control comparison showed substantially
higher serum cholesterol levels in 7 hospitalized
brain tumour patients than in hospitalized controls
with a variety of debilitating diseases (Basu et al.,
1974).
The objective of our study was to test the
hypothesis that a positive relationship exists
between high levels of serum cholesterol and
primary brain tumours (including meningeal
tumours).
Subjects and methods
A case-control study was performed based on the
hospital records of male Jewish residents of Israel
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who were hospitalized at the Hadassah Ein Karem
University Hospital in Jerusalem, which is the main
teaching hospital in the region and the only one
offering neurosurgery.
The group of cases comprised patients with a
diagnosis of primary brain tumour (excluding
tumour of the pituitary and pineal glands and the
craniopharyngeal duct) whose first hospitalization
for the disease occurred in this hospital between
1978 and 1982. In an attempt to locate all such
cases we searched for records of all male patients in
broad International Classification of Diseases
diagnostic categories that could include subjects
meeting our diagnostic criteria for inclusion. Of 261
such patients, the files of 221 (85%) were located.
Scrutiny of these records revealed that only 116
patients had a relevant diagnosis and were male
Jewish residents of Israel. Only 56 of these met the
full requirements for inclusion in this study, i.e.,
their first admission with a diagnosis of brain
tumour occurred in this hospital between 1978 and
1982. One patient was excluded because of a known
cancer of an additional site. Ten patients whose
hospital records had no data on serum cholesterol,
and 8 whose serum cholesterol was measured only
after operative, radiation or cytotoxic treatment
were excluded, leaving 37 of the 55 eligible cases
(67%) for analysis.
Controls were chosen from patients hospitalized
for inguinal hernia (without obstruction or gangrene)
in the same hospital during the same period. Two
controls were individually matched to each case
according to age (with age groups of 5 years up
to age 20-24, and of 10 years at older ages) and
year of hospitalization. For two cases, controls
were found only from the subsequent year. The
controls for each case were chosen randomly from
© The Macmillan Press Ltd., 198594 Z.H. ABRAMSON & J.D. KARK
all the patients with inguinal hernia who met the
respective matching criteria. If the hospital record
could not be obtained, ifthe patient was not suitable
for use as a control (non Jews, non residents of
Israel, a history of cancer, or hospitalization for
an acute disease), or if cholesterol data before
treatment were missing, a replacement was chosen
from the other potential controls meeting the
matching criteria. Half (52%) of the otherwise
suitable controls were discarded because of the
absence of a cholesterol measurement before
operation.
During the period covered by this study serum
cholesterol was measured on an autoanalyzer by
two methods: at the beginning of the study using a
modification of the Liebermann-Burchard reagent
(Huang et al., 1961) and later on by an enzymatic
method (Allain et al., 1974). Cases and controls
were matched also according to method of
cholesterol determination. The first measurement of
cholesterol appearing in the charts of each subject
was used in analysis.
One-sided significance tests were used, the null
hypothesis being that the serum cholesterol value
was not higher in the tumour cases. Mantel's
extension ofthe Mantel-Haenszel test (Mantel, 1963)
was applied by regarding each case and its controls
as a separate stratum. This method maintains the
individual matching and can also be used when the
number of controls is not constant (Schlesselman,
1982). For this test we divided the range of serum
cholesterol levels into 10 categories. The mean value
of all observations in each category was introduced
as the weight for that category. In Mantel's
extension procedure the regression coefficient of the
cholesterol value on the presence of brain tumour is
the mean difference between the cholesterol value
of the tumour cases and that of
the controls, adjusted for the variables according
to which the stratification was performed.
"Consistent" maximum likelihood estimates of the
odds ratios for brain cancer in the high and middle
tertiles of control serum cholesterol values
compared with the low tertile were obtained for
matched data (Pike et al., 1975; Rothman & Boice,
1979). Possible confounding variables, other than
those for which matching was performed, were
examined by using Mantel's extension test
restricting the analysis to only those pairs or triads
of cases and matched controls that were in the
same category of the specific variable; discordant
controls and cases with no concordant controls
were excluded. In this way the variable under
examination actually became an additional
matching criterion.
Little is known about the epidemiology of brain
tumours or of inguinal hernia, and some variables
were therefore treated as potential confounders
despite the absence of clear reasons for suspecting
such an effect. Potential confounders considered in
the analysis included: weight, which is associated
with cholesterol level (Kahn et al., 1969) and
possibly with inguinal hernia (Zimmerman &
Anson, 1967; Abramson et al., 1978); region of
birth, which is associated with cholesterol level
(Kahn et al., 1969; Halfon et al., 1982a) and with
brain tumours (Israel Cancer Registry, 1982); social
class which has been shown to be inversely
associated with cholesterol levels in a Jerusalem
study population (Harlap et al., 1982a) and
possibly with central nervous system tumour
incidence (Preston-Martin et al., 1982; Registrar
General, 1971); season of the year (Harlap et al.,
1982b) and smoking (Goldbourt & Medalie, 1977;
Halfon et al., 1982b; 1984) which are apparently
associated with cholesterol; and use of the drugs
diphenylhydantoin, barbiturates or glucocorticoids
which has been shown to be associated with higher
cholesterol levels (Nikkila et al., 1978; Pelkonen et
al., 1975). The length of hospitalization before the
measurement of cholesterol level was also
considered as a possible confounder. Information
on weight was not available in the charts. Thus,
body mass index or other measures that take
account ofheight could not be calculated.
The categories used for stratification in the
analysis were: region of birth grouped as Israel,
Asia-North Africa and Europe-America; season of
the year classified into two periods according to the
seasonal association with cholesterol levels reported
in the Jerusalem Lipid Research Clinic Study
(Harlap et al., 1982b): April to September with
lower levels and October to March with higher
levels; and social class, classified according to the
British Registrar General's method modified for use
in Israel (Kark et al., 1964), and grouped into high
(1+2), intermediate (3) and low (4+5). Cases and
their controls were considered in the same category
of height when their weight differed by 5kg or less.
Length of hospitalization before the measurement
of cholesterol was controlled by performing
Mantel's extension test only on those cases and
their controls where the length for the case was not
longer than that of its control. The effect of
medications was controlled by excluding from the
analysis those cases and controls who were
discordant for drug use.
Results
Fourteen of the cases had gliomas (37%), 11 had
meningiomas (30%), 4 had neurinomas (11%), and
in 8 the type was not specified (22%). Sixteen of
the 29 tumours with type specification had
histologic confirmation. Of the 18 cases that wereSERUM CHOLESTEROL AND PRIMARY BRAIN TUMOURS 95
not included in the study because of no cholesterol
measurement before treatment, 14 were gliomas, 3
had no type specification, and 1 was a carcinoma
of the choroid plexus.
Twenty-three of the 37 cases (62%) were over 55
years old, and only 3 (8%) were less than 24. The
controls were matched according to age group;
therefore, their age distribution was similar, the
average age of the cases being 53.6 years and that
of the controls 53.4.
Distributions of other variables in the cases and
the controls are presented in Table I.
The mean serum cholesterol value of the brain
tumour cases was 214.6mgdl-1 with a standard
deviation of 54.1 mgdl-1, and of the controls
192.2mgdl -1 with a standard deviation of
41.Omgdl-. Figure 1 shows the cumulative
frequency distribution of serum cholesterol' values
of the brain tumour cases and that of the controls.
It is apparent that the cholesterol values were
higher in the cases'throughout the distribution and
the difference in the means was not the result of a
few extreme outlying values.
The significance of the difference between cases
and controls was demonstrated by a paired t-test
(P=0.011) and by Mantel's extension of the
Mantel-Haenszel test (P=0.007). The strength of
the association between serum cholesterol
concentrations and brain tumour was evaluated
also by odds ratio estimates according to tertiles of
the control cholesterol concentrations. The odds of
the lowest tertile was set at unity. The odds ratio
estimates for the middle tertile was 2.7 and for the
high tertile was 5.5.
The difference between cases and controls
remained apparent and statistically significant when
weight, region of birth and other suspected
confounders were controlled by stratum restriction
(Table II). In some instances the adjusted difference
was larger than the crude difference.
Finally, we examined the cholesterol difference
for different tumour types. The cholesterol
Table I Comparison ofcharacteristics of cases and controls
Region ofbirth
Asia and North Africa
Europe and America
Israel
Month ofhospitalization
April to September
October to March
Social class
1
2
3
4
5
Total with data available
Smoking
Smoker
Non-smoker
Total with data available
Use ofmedication
Diphenylhydantoin
Barbiturate
Glucocorticoid
One or more of the above
None of the above
Day ofcholesterol measurement
1
2
.3
Weight (kg)
Mean (±s.d.)
Total with weight data available
Brain tumour
cases (37)
No. (%)
Controls
(74)
No. (%)
17 (23)
31 (42)
26 (35)
40 (54)
34 (46)
13 (26)
15 (30)
15 (30)
3 (6)
4 (8)
50 (100)
16 (28)
42 (72)
58 (100)
1 (1)
2 (3)
0
3 (4)
71 (96)
60 (81)
10 (14)
4 (5)
70.5 (±12.2)
63
9 (24)
20 (54)
8 (22)
20 (54)
17 (46)
6 (22)
3 (11)
12 (44)
3 (11)
3 (11)
27 (100)
6 (32)
13 (68)
19 (100)
4 (11)
9 (24)
3 (8)
14 (38)
23 (62)
2 (5)
27 (73)
8 (22)
68.7 (+ 12.9)
30
E/
/
/
/
0
/
/
p
/
/
0
140 160 180 200 220 240 260 280 300 320 340 360 380 400
Serum cholesterol (mg dl-')
Figure 1 Cumulative frequency distributions of serum cholesterol concentrations of 37 subjects with brain
tumours (0) and their 74 matched controls (El).
Table II Comparison of serum cholesterol of cases and controls controlling for effects of
possible confounding variables
Variable under No. of Adjusted cholesterol
control cases' difference (mgdl- )b pb
None 37 22.4 0.007
Weight 16 37.7 0.014
Region of birth 27 26.6 0.005
Season of the year 28 22.7 0.023
Social class 9 60.4 0.015
Use of medication 23 29.4 0.005
Length of hospitalization
before cholesterol measurement 14 42.8 0.009
aNumber of case control pairs or triads in the analysis - those discordant or with missing
data were excluded.
bMantel's extension of the Mantel-Haenszel procedure; the difference is for cases minus
controls.
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differences between the cases and their controls was
20mgdl -1 for gliomas (P=0.052 according to
Mantel's extension test), and 35mgdl-1 for the
group ofmeningiomas and neurinomas (P=0.036).
Discussion
The finding in this study that the mean cholesterol
value of the cases with brain tumour was
significantly higher than the mean value of the
controls strengthens the suspicion, based on the
smaller previous studies cited, that a positive
association exists between high levels of serum
cholesterol and primary brain tumours.
It is unlikely that the findings in the present
study are due to chance. In addition, all possible
confounding variables for which data were
available were taken into account; age was a
matching criterion. The difference in cholesterol
level between cases and controls remained apparent
when each of the other potential confounders was
controlled separately in the analysis. For some
variables (weight, social status, and length of
hospitalization before measurement of cholesterol)
the difference was enhanced when confounding was
controlled. It should be noted that the data on
weight, social status and smoking were not
complete and therefore a possible confounding
effect was not ruled out fully. According to the
available data, smoking was equally prevalent in
cases and controls.
The main reason for incompleteness of data was
that the study was based on routine hospital
records. The missing cholesterol values in some of
the hospital records, and the fact that other records
were not obtained, could result in bias. However,
this could have produced the observed association
if the null hypothesis is true only if a strong inverse
association with cholesterol existed in the cases and
controls who were omitted. This possibility cannot
be excluded. There was an overrepresentation of
gliomas in the cases excluded for missing data on
cholesterol level. The study findings were however
consistent for both the group of gliomas and that
of meningiomas and neurinomas.
Another possible source of error in the study is
the choice of controls. A relationship of serum
cholesterol with inguinal hernia (or with
hospitalization for the condition) could result in a
biased comparison. Patients with inguinal hernias
were chosen under the assumption that their
cholesterol levels are the same as those of the
source population from which the brain tumour
cases arose. As mentioned earlier, there may be an
association of hernia with weight and hence
possibly with cholesterol level. In a Jerusalem study
population hernia was associated with a somewhat
lower mean weight (Abramson et al., 1978). In our
study, however, the controls were heavier than the
cases. Controlling for weight in the analysis
enhanced the association.
The major question these results raise is, we
believe, that of temporal relationships; i.e., did high
levels of cholesterol precede the brain tumour or
did they become raised after occurrence of the
tumour? The case control design we employed, in
which serum cholesterol values were measured after
hospitalization for the tumour, has obvious
limitations in this regard.
The consistency with the two small prospective
studies in Israel suggests that elevated serum
cholesterol may precede the tumour. Ecologic data
in Israel are also consistent with the findings; Jews
of Asian and North African origin have both lower
blood cholesterol (Kahn et al., 1969; Halfon et al.,
1982a) and lower incidence of brain tumours (Israel
Cancer Registry, 1982) than European born. Their
intake of dietary fat is also lower (Kaufmann et al.,
1982a,b). Information on other variables, including
dietary intake, and particularly that of total fat and
saturated fatty acid, which may play a part in the
association between cholesterol level and brain
tumour, if elevated cholesterol precedes the tumour,
may help to explain the association. Additional
prospective studies would not only provide a more
persuasive test of the hypothesis but could also
throw light on the time relationship between serum
cholesterol levels and primary brain tumour.
However, vast study populations would be needed
to generate a sufficiently large number of brain
tumour cases to provide stable estimates. Pooling
data from large prospective studies in which blood
cholesterol (and dietary fat intake) have already
been measured or which have stored frozen serum
or plasma specimens can provide a rapid and more
definitive answer to this question. Further case-
control studies may be useful to examine
associations with various histological brain tumour
types.
This paper is based in part on a dissertation submitted by
Z.H.A. in partial fulfilment of the requirements for the
M.D. degree, Hebrew University-Hadassah Faculty of
Medicine, Jerusalem.
We thank the Records section of the Hadassah Uni-
versity Hospital, Ein Karem, Jerusalem, and the physicians
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